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Herpes simplex virus (HSV) has evolved multiple strategies to modulate host immune responses. In a
screen of HSV open reading frames to identify additional HSV-encoded proteins that affect NF-kB
signaling, we identiﬁed the viral US3 tegument protein as an inhibitor of NF-kB signaling. We found
that the US3 protein is required for inhibition of TLR2 signaling induced by viral infection and that this
inhibition occurs at very early times post-infection. Expression of US3 in transfected cells inhibits TLR2
signaling induced by Zymosan, and this inhibition occurs at or downstream of MyD88 and upstream of
p65. Polyubiquitination of TRAF6 is critical for its function in TLR2 signaling. Using US3-null and US3
kinase-defective mutant viruses, we demonstrate that HSV US3 reduces TRAF6 polyubiquitination and
that the kinase activity of US3 is necessary for this effect. Therefore, US3 is necessary and sufﬁcient for
inhibiting TLR2 signaling at or before the stage of TRAF6 ubiquitination.
& 2013 Elsevier Inc. All rights reserved.Introduction
One of the ﬁrst critical lines of defense by a host organism against
an invading virus is its innate immune system. The earliest events of
innate immune responses include sensing of virus components by
host pattern recognition receptors (PRRs), which initiate signaling
cascades and transcriptional activation of genes encoding type I
interferons (IFNs) and pro-inﬂammatory cytokines. These signaling
pathways are complex mechanisms that engage a variety of cell
types (inﬂammatory cells, dendritic cells and lymphocytes) to control
viral infection and are tightly regulated. In addition to type I IFNs,
which mediate the early antiviral response to a large extent,
cytokines (like IL-1b, IL-6, IL-8, IL-18 and IL-12) induced by innate
immune cells are also critical for an effective early antiviral defense.
Pathogen sensing triggers a cascade of intracellular signaling events
involving a large number of adaptor proteins. Sequential steps of
post-translational modiﬁcations on these proteins, such as phosphor-
ylation and ubiquitination, result in the translocation of transcription
factors such as NF-kB, AP-1, or JNK to the nucleus where they
stimulate the transcription of antiviral and pro-inﬂammatory genes.
These events function to curb early events in productive viral
infection as well as to program the adaptive immune response. Not
surprisingly, viruses have also evolved numerous mechanisms to
blunt or evade these protective measures elicited by the host.ll rights reserved.
.M. Knipe).
eases, National Institutes ofNF-kB is a major transcriptional activator for pro-inﬂammatory
cytokine genes (Hayden et al., 2006), and herpes simplex virus (HSV)
infection activates the NF-kB signaling pathway by both TLR-
dependent and -independent pathways resulting in the induction
of cytokines IL-6 and IL-8 (Hilton et al., 1995; Kurt-Jones et al., 2005,
2004). Upon microbial recognition, TLR2 dimerizes with either TLR1
or TLR6 and recruits MyD88 and Mal/TIRAP through TIR domain
interactions. This complex then recruits the IRAKs (IL-1 receptor-
associated kinases). IRAK4 is recruited ﬁrst, becomes activated and
phosphorylates IRAK-1, which activates IRAK-2. IRAK activation leads
to an interaction with TRAF6 (tumor necrosis factor receptor-
associated factor 6) and oligomerization of TRAF6 and its autoubi-
quitination. TRAF6, an E3 ubiquitin ligase, catalyzes the synthesis of
polyubiquitin chains (polyUb) bound to itself and TAK1, thereby
activating TAK1. The polyUb chains bind to NEMO, the regulatory
component of the IKK complex. The resulting complex leads to
phosphorylation of IKKb by TAK1, leading to activation of the IKK
complex, which phosphorylates the a subunit of IkB (inhibitor of
kB), causing its ubiquitination and degradation, release of NF-kB and
its translocation into the nucleus. Nuclear NF-kB binds to kB
elements in enhancers and promoters and also to the basal tran-
scriptional machinery to activate transcription (Oliveira-Nascimento
et al., 2012; Rathinam and Fitzgerald, 2011).
The TLR2 dependence for HSV induction of NF-kB signaling is cell
type-speciﬁc (Rathinam and Fitzgerald, 2011). We have shown that
infection with HSV-1 wild-type (WT) strains KOS and F can activate
TLR2 signaling in mouse macrophages and human cells expressing
TLR2 (Kurt-Jones et al., 2005, 2004). Further, while TLR2 is essential
for the recognition of HSV and induction of pro-inﬂammatory
cytokines by macrophages, microglial cells and myeloid dendritic
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dendritic cells (pDCs) can sense HSV in a TLR2-independent fashion
(Rasmussen et al., 2007; Sato et al., 2006). Recently, it has also been
reported that in response to HSV infection, type I interferon produc-
tion in inﬂammatory monocytes is partially dependent on TLR2
(Barbalat et al., 2009). Moreover, TLR2 recognition of HSV in vivo
appears to depend on route of inoculation and virus subtype. In the
case of HSV-2 infection in mice, although TLR2 appears to be non-
essential for the control of viral spread following intraperitoneal or
vaginal infection, an effective cytokine response in the brain follow-
ing natural vaginal infection is dependent on a synergistic role of
TLR2 and TLR9 (Sorensen et al., 2008). In the corneal and intraper-
itoneal infection models in mice, TLR2 sensing of HSV has been
shown to mount an excessive immune response that can be
detrimental to the host (Kurt-Jones et al., 2004; Sarangi et al.,
2007). Interestingly, in humans, two polymorphisms in TLR2 are
associated with increased HSV-2 viral shedding and increased lesions
(Bochud et al., 2007), supporting a role for TLR2 in the control of
virus infection. In addition, work done by Iwasaki and colleagues
indicated that TLR2 sensing of HSV-1 is virus strain/clone-dependent
(Sato et al., 2006), although the molecular mechanism underlying
this phenomenon is not known. It has been recently demonstrated
that HSV gB and gH/gL proteins interact with TLR2, but gH/gL alone
are capable of triggering NF-kB activation (Leoni et al., 2012).
HSV gene products have been shown to regulate NF-kB signal-
ing in a number of ways. HSV infection activates NF-kB signaling,
which is essential for optimal viral replication (Amici et al., 2001;
Patel et al., 1998). It has been demonstrated that ICP27 is essential
for NF-kB induction (Hargett et al., 2006). The virion UL37 protein
was shown to activate NF-kB signaling by interacting with and
activating TRAF6 (Liu et al., 2008). Infection with UV-inactivated
virus and binding of gD to HVEM can also lead to activation of NF-
kB (Medici et al., 2003; Sciortino et al., 2008). In contrast, HSV-1
ICP0 inhibited NF-kB signaling by reducing levels of adaptor
proteins (van Lint et al., 2010). Therefore, the net induction of
NF-kB signaling by HSV is the result of the combined activities of
HSV proteins that both activate and inhibit NF-kB signaling.
In this study, in a screen of the HSV open reading frames
(ORFs) to identify additional proteins that modulate NF-kB
activity, we identiﬁed the HSV US3 tegument protein as an
inhibitor of the NF-kB signaling pathway. The HSV-1 US3 protein
kinase is a virion tegument protein that has been implicated in a
variety of processes during productive virus infection. Most
notable among them are its roles in virion maturation and egress
(Favoreel et al., 2005; Matsuzaki et al., 2005; Mou et al., 2007;
Reynolds et al., 2002; Wisner et al., 2009), in preventing virus-
induced apoptosis (Benetti and Roizman, 2004; Hata et al., 1999;
Leopardi et al., 1997; Munger and Roizman, 2001; Ogg et al.,
2004), enhancing histone acetylation (Gu et al., 2005; Poon et al.,
2006), suppression of the IFNg response by down-regulating the
IFNAR-1 receptor (Liang and Roizman, 2008), and more recently,
in stimulating mRNA translation (Chuluunbaatar et al., 2010). In
this study we show that US3 also down-regulates TLR2-dependent
NF-kB signaling at very early times post infection, and we found
that this inhibition of TLR2 signaling occurs before or at the stage
of TRAF6 ubiquitination.Fig. 1. HSV-1 US3 inhibits Zymosan activation of TLR2. TLR2-expressing cells
(H2.14.12 cells) were transfected with NF-kB-driven ﬁreﬂy luciferase reporter and
thymidine kinase promoter-driven Renilla luciferase (TK-Renilla) plasmids,
together with increasing amounts of US3 plasmid and pcDNA3.1 empty vector
to keep the total plasmid amount constant. After 24 h, transfected cells were
treated with Zymosan or mock-treated (without Zymosan), and at 6 h post
stimulation ﬁreﬂy and Renilla luciferase activities were measured using the
Promega dual-glo luciferase assay system. Results are presented as normalized
luciferase activity.Results
Construction of an HSV-1 ORF expression plasmid library and
identiﬁcation of US3 as an inhibitor of NF-kB signaling
HSV-1 encodes at least 84 ORFs (Roizman et al., 2007) and has
the ability to activate the NF-kB signaling pathway (Patel et al.,
1998; Santoro et al., 2003). To identify additional HSV proteinsthat modulate NF-kB activity, we constructed an HSV-1 cDNA
library and performed a reporter gene assay-based screen of the
HSV proteome. The HSV-1 ORFs were PCR-ampliﬁed from geno-
mic DNA of low passage HSV-1 KOS strain. Each PCR product was
inserted into the pcDNA3.1 plasmid vector so that the ORF was
tagged with a C-terminus V5-epitope and 6XHis motif for easy
detection of protein expression. A total of 66 ORF-expressing
plasmids were constructed, and following veriﬁcation by sequen-
cing, protein expression was conﬁrmed by western blotting (Liu
and Knipe, unpublished results).
To screen the effects of the viral gene products on NF-kB activity,
we performed an NF-kB-dependent luciferase reporter assay, which
measures overall NF-kB activity directly as described before (Liu
et al., 2008). Brieﬂy, HEK293T cells were cotransfected with an NF-
kB-dependent ﬁreﬂy luciferase reporter plasmid, a CMV promoter/
enhancer b-galactosidase reporter plasmid as a transfection efﬁ-
ciency control, and a plasmid expressing an HSV-1 ORF. Induction of
NF-kB activity was measured by the expression of ﬁreﬂy luciferase
and normalized to b-gal activity. Over-expression of p65, which
enhances the basal level of reporter-gene activity, was used as a
positive control. Among the 66 HSV-1 ORFs screened for their ability
to affect NF-kB -reporter activity in HEK293T cells, the majority had
minimal effect, a few ORFs stimulated NF-kB activity (e.g., UL37, (Liu
et al., 2008)), while a few HSV-1 proteins reduced the basal level of
reporter gene activity (results not shown). In the latter group, we
identiﬁed the HSV-1 tegument protein US3 as a potential inhibitor of
the NF-kB activation pathway. This observation led us to hypothe-
size that US3 may play a role in immune evasion by suppression of
NF-kB activity. To conﬁrm this result, we used HEK293 cells stably
expressing TLR2 (H2.14.12 cells) to determine whether US3 could
block NF-kB signaling triggered by Zymosan, a well-characterized
TLR2 agonist. H2.14.12 cells were transfected with various amounts
of US3 expression plasmid together with NF-kB-luciferase reporter
and TK-Renilla control plasmids. At 24 h post-transfection the cells
were treated with Zymosan or mock treated for 6 h, and then the
NF-kB-driven ﬁreﬂy luciferase and Renilla luciferase activities were
measured in the cell lysates. Zymosan stimulation led to a robust
TLR2-driven luciferase activity compared to the empty vector
transfected mock-treated sample, but expression of US3 reduced
luciferase activity signiﬁcantly (almost to basal level) and in a dose-
dependent manner (Fig. 1). These results argued for an inhibitory
role for US3 in TLR2 signaling.
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upstream of p65
To identify the step of the NF-kB activation pathway targeted
by US3, we tested the effect of US3 on NF-kB induction with various
stimuli. Over-expression of individual components of the signaling
pathway downstream of TLR2 activation, for example MyD88,
TRAF6 or a subunit of NF-kB (p65), is sufﬁcient to trigger NF-kB
signaling (Fitzgerald et al., 2001). Therefore, we investigated
whether US3 could block the stimulatory signal induced by over-
expression of MyD88 or p65. HEK293 T cells were transfected with
the NF-kB-luciferase and TK-Renilla plasmids and either MyD88 or
p65 plasmid with or without the US3 plasmid and empty vector to
keep the total DNA amount constant. The empty vector transfected
sample was used as a control and luciferase activity was measured
at 24 h post-transfection. As expected, expression of MyD88 or p65
alone was sufﬁcient to activate NF-kB, resulting in robust lucifer-
ase activity (Fig. 2A). Co-expression of US3 resulted in a signiﬁcant
reduction in the MyD88-induced luciferase activity, showing that
ectopic expression of US3 alone was capable of inhibiting NF-kB
activation. In contrast, p65-driven NF-kB activity was not affected
by co-expression of US3, arguing that the US3 effect is upstream of
nuclear translocation of activated p65 and its binding to DNA.
Taken together, these results showed that US3 functions down-
stream of MyD88 but upstream of p65.
To test the speciﬁcity of US3, we examined the effect of US3 on
other signaling pathways. US3 did not affect TBK-1-driven activa-
tion of ISRE-luciferase reporter levels and led to only a small
reduction in TRAF2-driven NF-kB activation (Fig. 2B). This inhibi-
tion was much smaller than what we observed for signaling
downstream of MyD88 and could be due to an indirect effect of
US3 overexpression in the cell, especially because this viral kinase
is known to be a multifunctional protein. This demonstrated that
the inhibitory effect of US3 shows at least some speciﬁcity for the
MyD88–TRAF6–NF-kB cascade.US3-mediated inhibition of NF-kB signaling occurs upon HSV-
triggered TLR2 activation
To extend the transfection studies to virus infection, we
assessed induction of NF-kB activity after virus infection in TLR2þ
HEK293 (H2.14.12) cells by measuring the levels of IL-8, which isFig. 2. (A) HSV-1 US3 inhibits NF-kB signaling downstream of MyD88 and upstream o
with either MyD88 or p65 plasmids, with or without US3 plasmid and empty vector to
transfection. Results are presented as fold induction of luciferase activity over empty vec
signaling. Cells were transfected with NF-kB-luciferase and TK-Renilla plasmids along w
to keep the plasmid amount constant. Luciferase activity was measured at 24 h post tr
empty vector-transfected control.an NF-kB-activated pro-inﬂammatory cytokine, in cells infected
with the R7041 mutant virus strain with a deletion in the US3
gene or its rescued viral strain, R7306 (Purves et al., 1991). We
collected extracellular supernatants at 6 h post-infection (hpi)
and analyzed them for levels of IL-8 by ELISA. We observed that
the amount of IL-8 secreted into the medium was signiﬁcantly
higher in the US3 deletion virus-infected cells compared to the
WT or US3 rescued virus-infected cells (Fig. 3A). Importantly, in
HEK293 T cells that do not express TLR2, there was no detectable
increase in IL-8 level in the cell supernatant, showing that the
induction was via TLR2. The inhibition of TLR2 signaling involving
US3 was apparent starting at very early times post-infection
(Fig. 3B). Signiﬁcantly higher levels of IL-8 were detected in the
cell supernatant as early as 2–3 hpi with R7041 compared with
WT virus infection, and this difference was maintained at least
through 7 hpi. Moreover, when TLR2þ cells were infected at
different MOIs, we observed that the induction of IL-8 was virus
dose-dependent (Fig. 3C). Similar results were observed in murine
macrophages, which are known to play a critical role in the early
stages of the antiviral response, in part by releasing pro-
inﬂammatory cytokines upon activation. In RAW264.7 cells,
a murine macrophage-like cell line derived from Balb/C mice,
a similar trend was observed for NF-kB-induced proinﬂammatory
cytokine genes (Fig. 3D). RAW264.7 cells were infected with
either WT or US3 deletion mutant virus, and at 6 hpi the levels
of IL-6 and CCL2 mRNA were measured by RT-PCR. In comparison
to WT virus infection, infection of RAW cells with the US3 deletion
virus resulted in signiﬁcantly higher levels of IL-6 mRNA. Induc-
tion of CCL2 mRNA was also higher in deletion virus-infected
cells, although to a somewhat lower extent. Because the US3
deletion virus showed signiﬁcantly higher NF-kB activity down-
stream of TLR2 activation compared to both WT and US3 rescued
viruses, we concluded that the mutant phenotype was due to the
absence of US3.
Because HSV-1 US3 is a component of the virion tegument and
is carried into host cells at the time of infection along with other
tegument proteins, we determined whether equivalent amounts
of virion tegument proteins like VP16 and UL37 were being
introduced into the cells upon infection with WT, R7041 and
R7306 viruses. We therefore analyzed equivalent numbers of
infectious virus particles (based upon equal numbers of PFUs)
by SDS-PAGE and Western blotting to conﬁrm that comparable
quantities of virion tegument proteins were present in the virusf p65. Cells were transfected with NF-kB-luciferase and TK-Renilla plasmids along
keep the plasmid amount constant. Luciferase activity was measured at 24 h post-
tor-transfected control. (B) HSV-1 US3 does not inhibit TRAF2- and TBK1-mediated
ith either TRAF2 or TBK1 plasmid, with or without US3 plasmid and empty vector
ansfection. Results are presented as fold induction of luciferase activity relative to
Fig. 3. (A) US3-mediated inhibition of IL-8 induction in infected cells is TLR2-dependent. H2.14.12 cells (TLR2
þ) and HEK293T cells (TLR2-) were infected with wild-type
(WT), R7041 (US3
-) or R7306 (US3R) virus, and at 6 hpi accumulation of IL-8 in the cell supernatant was measured by ELISA. (B) US3-mediated inhibition of the TLR2
signaling pathway occurs very early after virus infection. TLR2þ cells were infected with wild-type (WT) or R7041 (US3
-) virus at an MOI of 20. At various time points post-
infection, levels of IL-8 secreted into the cell supernatant were measured by ELISA. (C) US3-mediated inhibition of NF-kB activation is dose-dependent. TLR2þ cells were
infected with wild-type (WT), R7041 (US3
) or R7306 (US3R) virus at an MOI of 0.2, 2 or 20, and at 6 hpi, accumulation of IL-8 in the cell supernatant was measured by
ELISA. (D). Relative cytokine mRNA levels in infected murine macrophage cells. At 6 hpi with the indicated viruses, mRNA levels were measured by real time PCR. (E)
Expression of HSV-1 ICP0 protein in virus infected Vero cells. Cells were infected with wild-type (WT), R7041 (US3
) or R7306 (US3R) viruses at an MOI of 20, and ICP0
expression was evaluated by Western blotting of infected cell lysates harvested at 2, 3 and 4 hpi. (F) Relative amounts of tegument proteins in viral particles. Equivalent
numbers of infectious viral particles were resolved on SDS-PAGE, and virion proteins were detected by Western blot. Wild-type (WT), R7041 (US3
), R7306 (US3R).
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and R7306 virus stocks had comparable levels of VP16, another
tegument protein (Fig. 3F). Furthermore, we observed that com-
parable levels of the immediate-early ICP0 protein were
expressed by 3 hpi in Vero cells infected with these viruses
(Fig. 3E).Fig. 4. Effects of infection on localization of NF-kB and levels of IkB. TLR2þ
HEK293 cells were infected with wild-type (WT), Us3 deletion (US3
) or US3
rescued (US3R) virus. At the indicated time points, cellular fractionation and
Western blot analyses were performed. (A) Nuclear levels of NF-kB. (B) Cytoplas-
mic levels of IkB.US3 inhibits nuclear accumulation of p65
We have shown that US3 inhibits NF-kB activity upstream of
p65 and that the US3-mediated effect occurs early during infection,
i.e., by 2–3 hpi. This suggested that the US3 protein carried in with
the virion tegument might bring about the observed inhibitory
effects. In unstimulated cells, the IkB protein sequesters NF-kB in
the cytoplasm. Upon TLR2 stimulation, IkB is phosphorylated,
ubiquitinated and degraded, allowing active NF-kB to translocate
to the nucleus. Therefore, the increased nuclear accumulation of
the NF-kB subunit p65 provides a direct and quantitative measure
of NF-kB activation. To determine if there was differential nuclear
translocation of p65 at early times after infection with WT or US3
deletion mutant viruses, we infected TLR2þ HEK293 cells with WT,
R7041 or R7306 virus strains and carried out cellular fractionation
at various times to compare nuclear versus cytoplasmic NF-kB
levels. By 1 hpi, there was increased nuclear accumulation of p65
in the US3 null (R7041) virus-infected cells compared to WT virus-
infected cells, and this continued through 6 hpi (Fig. 4A). Consis-
tent with increased nuclear p65 levels, there was a decrease in
cytosolic IkB levels in R7041 virus-infected cells (Fig. 4B). In cells
infected with the US3 rescued virus (R7306), the level of nuclear
NF-kB was comparable to that of the WT virus-infected cells,
further arguing that the increased nuclear translocation of NF-kB
was speciﬁcally due to the absence of US3. Moreover, because this
effect was observed at a time when there was little or no late geneexpression, it seemed likely that virion US3 acts to inhibit the
canonical NF-kB activation pathway.
US3 inhibits TRAF6 ubiquitination
Having established that HSV US3 dampens TLR2 signaling by
causing inhibition of nuclear translocation of NF-kB, we then
investigated how US3 might exert this effect. We have demon-
strated that HSV ICP0 modulates innate responses by reducing the
levels of sensor or adaptor components of innate signaling path-
ways within the host cell (Orzalli et al., 2012; van Lint et al., 2010).
To examine the effect of US3 on TLR2-activated NF-kB signaling,
we transfected HEK293 T cells with HA-MyD88, Flag-IRAK-1,
Fig. 5. Effects of US3 on adaptor proteins in transfected cells. HEK293T cells were transfected with (A) HA-Myd88 with (lane 3) or without (lane 2) US3-expressing plasmid,
(B) Flag-TRAF6 with (lane 3) or without US3 (lane 2), (C) Flag-IRAK1 with (lane 1) or without (lane 2) US3 and Flag-TAK1 with (lane 3) or without (lane 4) US3, as indicated.
Empty vector transfected cells were used as control (mock, lane 1 in (A) and (B)). Cell lysates were analyzed by Western blotting using anti-HA antibody (for MyD88) and
anti-Flag antibody (for TRAF6, IRAK1, TAK1 and US3). (D) Effect of US3 on TRAF6 ubiquitination. HEK293T cells were transfected with Flag-TRAF6 and HA-Ubiquitin
plasmids with (lane 4) or without (lane 3) the US3 plasmid. Empty vector transfected cells were used as control (lane 1). Lysates were immunoprecipitated with TRAF6
antibody and analyzed by Western blotting using the anti-ubiquitin antibody. TRAF6 and US3 were detected using the anti-Flag antibody (lower panel).
J. Sen et al. / Virology 439 (2013) 65–73 69Flag-TRAF6 and Flag-TAK1 plasmids with or without a Flag-US3
plasmid, and measured the levels of MyD88, IRAK-1, TRAF6 and
TAK1 proteins in cell lysates in the presence or absence of US3. Co-
expression of US3 had no detectable effect on the adaptor protein
expression levels (Fig. 5A–C). Thus, there was no evidence that
levels of signaling proteins were altered by US3.
A pivotal step in the TRAF6 signaling pathway is the ubiqui-
tination of TRAF6 and recruitment of signalosome protein com-
ponents like TAK1, TAB2, and TAB3 (Chen, 2005). It has also been
shown recently that inhibition of TRAF6 ubiquitination or the
deubiquitination of TRAF6 results in inhibition of downstream
NF-kB signaling (Shembade et al., 2010). We hypothesized that
HSV US3 interferes with TRAF6 ubiquitination and therefore
examined its effect on TRAF6 ubiquitination. To test our hypoth-
esis, we transfected HEK293 T cells with Flag-TRAF6 and HA-
Ubiquitin plasmids with or without the Flag-US3 plasmid. We
observed that US3 expression dramatically reduced the levels of
TRAF6 polyubiquitination in cotransfected cells (Fig. 5D). This
argued that US3 modulates NF-kB signaling by inhibiting the
polyubiquitination of TRAF6.
To study a more biologically relevant situation, we then looked
at the effects of viral infection on endogenous TRAF6 ubiquitina-
tion. We infected TLR2þ HEK293 cells with WT or US3 deletion(R7041) virus strains. Because the US3 inhibitory effects occurred
at early times post infection, we harvested and prepared infected
cell lysates at 1 and 2 hpi and immunoprecipitated endogenous
TRAF6 protein. Similar to the transfection experiments described
above, levels of endogenous TRAF6 were comparable in cells
infected with WT or US3 deletion virus (Fig. 6). However, we
observed that by as early as 1 hpi, R7041 virus-infected cells had
higher levels of polyubiquitinated TRAF6 compared to WT virus-
infected cells (Fig. 6), suggesting that in the presence of US3
polyubiquitination of endogenous TRAF6 was inhibited. There-
fore, at very early times post-infection HSV US3 inhibits the
signaling pathway at or prior to TRAF6 ubiquitination.
US3-inhibition of NF-kB is dependent on its kinase function
HSV US3 protein is a kinase with a broad speciﬁcity for both
cellular and viral proteins. To determine whether the US3 Ser/Thr
kinase activity was required for inhibition of NF-kB activity down-
stream of TLR2 activation, we mock-infected or infected TLR2þ
HEK293 cells with R7041 US3 deletion virus, the K220A mutant
virus expressing catalytically inactive US3, the R7306 US3 rescued
virus, or WT virus. When we analyzed infected cell supernatants
for levels of IL-6 and IL-8 by ELISA, we observed that R7041 and
Fig. 6. Effect of US3 on TRAF6 ubiquitination in infected cells. H2.14.12 cells were
infected with wild-type (WT, lanes 2,3) or US3 deletion (US3
 , lanes 4,5) virus. At
the indicated time points, cell lysates were prepared as described in Materials and
Methods and analyzed by IP of TRAF6, followed by Western blot for Ub.
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much higher levels than WT or R7306 viruses (Fig. 7A), consistent
with previous results obtained with the R7041 virus. Moreover, the
R7041 and K220A viruses induced comparable levels of IL-6 and IL-
8, indicating that the inhibition of NF-kB activation is dependent
on the kinase activity of US3. We then determined the effect on
TRAF6 polyubiquitination in K220A-infected H2.14.12 cells. As in
our previous experiments, endogenous TRAF6 was immunopreci-
pitated from mock or infected cell lysates and TRAF6 polyubiqui-
tination level was determined by Western blotting using an anti-
Ubiquitin antibody. We observed that both R7041 (US3 deletion)
and K220A (US3 kinase-inactive) viruses led to signiﬁcantly higher
levels of polyubiquitination of endogenous TRAF6, compared to
either WT or R7306 (US3 rescued) virus (Fig. 7B). This observation
was also consistent with the IL-6 and IL-8 ELISA assays, which
measured active NF-kB downstream of TRAF6 ubiquitination and
activation.Fig. 7. Role of the US3 protein kinase activity in inhibition of NF- kB. (A) Role in
cytokine induction. TLR2þ cells were mock infected or infected with wild-type
(WT), R7041 (Us3–), R7306 (Us3 deletion) or K220A (Us3 kinase-deﬁcient) virus. At
6 hpi IL-6 and IL-8 levels in the cell supernatant were measured by ELISA. (B) Role
in TRAF6 ubiquitination. TLR2þ cells were mock infected (Lane 1) or infected with
WT (Lane 2), Us3– (Lane 3), K220A (Lane 4) and R7306 (Lane 5) virus. At 2 hpi, cell
lysates were analyzed by IP-Western. Endogenous TRAF6 was immunoprecipi-
tated with anti-TRAF6 antibody, and polyubiquitination was detected using the
anti-ubiquitin antibody.Discussion
In a screen of HSV ORFs to identify viral proteins that modulate
NF-kB signaling, we identiﬁed the US3 virion tegument protein as
an additional viral-encoded inhibitor of NF-kB signaling. Trans-
fection studies showed that US3 alone is sufﬁcient to block NF-kB
signaling at or between MyD88 and TRAF6 adaptor proteins.
Further studies in cells infected with a US3 deletion mutant virus
and rescued virus showed that US3 is required for a viral
mechanism that restricts TLR2 signaling. This inhibition occurs
at or prior to TRAF6 ubiquitination because the rescued virus and
WT viruses showed lower TRAF6 ubiquitination than the US3 null
mutant virus. Furthermore, the inhibition of p65 nuclear localiza-
tion occurred as early as 1–2 hpi, consistent with a possible role
for the virion tegument US3 protein in this inhibition. A kinase-
dead US3 mutant virus also showed elevated NF-kB signaling,
arguing for a role for the kinase activity in the US3 inhibitory
effect. This work adds to the growing list of HSV proteins that
modulate NF-kB and TLR2 signaling.
Mechanism of US3-mediated NF-kB inhibition
The HSV US3 gene encodes a serine/threonine protein kinase
with an amino acid sequence that is conserved in members of theAlphaherpesvirinae sub-family (Frame et al., 1987; McGeoch and
Davison, 1986). We found no evidence that US3 affected the levels of
signaling proteins; therefore, US3 could modulate this signaling
pathway by affecting the activities of the signaling adaptor proteins
by phosphorylation of any of the components from TLR2 to TRAF6.
Inhibition of signaling could be due to (1) phosphorylation of
adaptor proteins directly, which could lead to an inhibition of
signaling, (2) phosphorylations blocking the interaction of the
protein with other adaptor proteins in the pathway, or (3) phos-
phorylations that recruit other enzymes such as cellular or viral
deubiquitinases that reverse the ubiquitination of TRAF6. The US3
kinase targets a broad range of substrates within the cell, and
several studies have implicated US3 in a variety of processes during
the virus life cycle as reviewed in the introduction. None of the
known substrates for US3 provide a ready explanation for its NF-kB
inhibitory activity as none are known to affect NF-kB signaling.
Interestingly, phosphorylation of the retinoic acid-inducible gene I
J. Sen et al. / Virology 439 (2013) 65–73 71(RIG-I) prevents its ubiquitination by TRIM25 (Gack et al., 2010);
thus, a similar mechanism could be operative here in which
phosphorylation of TRAF6 by US3 prevents the autoubiquitination
of TRAF6. The substrate speciﬁcity of the US3 kinase is similar to that
of protein kinase A of the host cell (Benetti and Roizman, 2007).
There are precedents for PKA phosphorylation modulating the
activities of other proteins in that an inhibitory phosphorylation
by PKA has been shown to modulate the activity of Naþ–Kþ–
ATPase in response to beta-adrenergic hormone (Cheng et al., 1997).
PKA is known to affect NF-kB signaling, but the documented effects
are all at the level of IKK or post-translational modiﬁcations of p65/
Rel (Gerlo et al., 2011). Therefore, these effects would not be
candidates for modiﬁcation of TRAF6 ubiquitination.
US3 may also tap into normal cellular mechanisms for regula-
tion of TRAF6 ubiquitination. It has been demonstrated recently
that the cellular USP25 protein negatively regulates IL-17-
mediated TRAF6 signaling by deubiquitinating TRAF6 (Zhong
et al., 2012), and SYK-mediated phosphorylation of USP25 alters
cellular levels of USP25 (Cholay et al., 2010). Because US3 has
diverse phosphorylation targets, it is worthwhile to test whether
USP25 is a target of US3 kinase activity or is recruited to TRAF6 by
US3. Further experiments are necessary to dissect out these
potential mechanisms of US3-mediated inhibition, and experi-
ments to test these hypotheses are currently underway.
Regulation of NF-kB signaling by HSV
It is noteworthy that HSV encodes multiple proteins that
appear to modulate NF-kB signaling in various ways. The incom-
ing virion contains both the UL37 protein, which stimulates NF-kB
signaling through its interaction with TRAF6 (Liu et al., 2008), and
the US3 protein, which inhibits NF-kB signaling (this report). We
show here that US3 leads to decreased TRAF6 ubiquitination while
other studies have shown that UL37 leads to increased ubiquiti-
nation of TRAF6 (Yan, Liu and Knipe, manuscript in preparation).
The virion gD is also thought to stimulate NF-kB signaling (Medici
et al., 2003; Sciortino et al., 2008) so multiple virion proteins
affect NF-kB signaling. Once the immediate-early proteins are
expressed, the ICP0 protein can inhibit TLR2 signaling (van Lint
et al., 2010), and the ICP27 protein leads to a stimulation of NF-kB
signaling in cells that do not express TLR2 (Hargett et al., 2006).
This complex regulation and the opposing effects of these pro-
teins may have evolved to provide some NF-kB stimulation to
allow optimal replication and infected cell survival while restrict-
ing the NF-kB stimulation so that a strong antiviral innate
response is not induced. This regulatory network may also have
evolved to allow the virus to differentially regulate NF-kB signal-
ing in cells that express TLR2 (Kurt-Jones et al., 2004), versus
those that do not express TLR2 (Hilton et al., 1995).
Variability in HSV strains (Sato et al., 2006) or in different
stocks (van Lint, Sen and Knipe, manuscript in preparation) to
activate TLR2 has been observed. Two viral factors have now been
shown to regulate NF-kB signaling: (1) ICP0 inhibits TLR2 signal-
ing, possibly by affecting the levels of adaptor proteins (van Lint
et al., 2010), and (2) US3 has been shown here to inhibit TLR2
signaling at or before the stage of TRAF6 ubiquitination. The
effects of both of these proteins are exerted early following
infection and therefore could be exerted through virion proteins
or proteins expressed very early in the infection process. There-
fore, epigenetic effects could lead to variability in virion protein
content or modiﬁcation or levels of expression during the initial
stages of infection and explain the variability of HSV-1 stocks to
activate NF-kB signaling.
HSV-1 is the causative agent of severe diseases like keratitis
and neonatal encephalitis, and HSV-2, the causative agent of
genital herpes, has also been implicated in augmenting the riskof HIV transmission. Moreover, HSV also has clinical importance
as a gene delivery and vaccine vector agent. The complete set of
HSV gene products that potentiate or modulate innate immune
responses is still unknown and therefore, a thorough mechanistic
understanding of host anti-viral responses is central to the
development not only of anti-viral therapeutics and vaccines
but also to improve the safety of viral vectors in gene therapies.Materials and methods
Cell lines and viruses
The HEK293 cell line stably expressing TLR2 (H2.14.12) was
described previously (Kurt-Jones et al., 2002). The wild-type (WT)
HSV-1 F strain was propagated and viral stock titers were
determined on Vero cells. The HSV-1 US3 null (R7041) and US3
rescued (R7306) virus strains (Purves et al., 1991) were provided
by Dr. Bernard Roizman (University of Chicago, Chicago, IL).
R7041, R7306 and the US3 kinase-dead K220A (Ryckman and
Roller, 2004) virus strains were propagated and titered on Vero
cells. For all experiments, cell-free virus stocks were prepared
from infected cell supernatants, and virus titers were determined
on Vero cells by standard plaque assay. The HEK293T, H2.14.12
and murine macrophage cells (RAW264.7) were maintained in
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% FBS
(DMEM-10).
Plasmids
HSV expression plasmids used in this study were constructed by
PCR ampliﬁcation of individual ORFs from genomic DNA isolated
from low passage HSV-1 KOS virus and subcloning into the
pcDNA3.1 vector (Invitrogen). These constructs express the HSV
proteins in-frame with a V5 and 6xHis tag (or Flag tag in some
cases), for easy detection of protein expression. All plasmid inserts
were sequenced at the Dana Farber Cancer Center Sequencing
Facility, and HSV protein expression was conﬁrmed by transfection
and Western blot analysis using anti-V5 or Flag antibodies.
Luciferase, IL-6 and IL-8 cytokine assays
Luciferase reporter assays were carried out as described
previously (Liu et al., 2008). For the HSV ORF screen, HEK293 T
cells were transfected in 96-well plates with NF-kB-driven ﬁreﬂy
luciferase (NF-kB-luciferase) reporter plasmid, b-galactosidase
(b-gal) expressing plasmid as transfection control, and each of
the plasmids encoding HSV proteins. At 24 h post-transfection the
luciferase activity was measured in cell lysates. Luciferase levels
were normalized to b-galactosidase activity, and fold-induction
values were calculated relative to the normalized activity of
empty vector transfected sample. In other luciferase assays,
HEK293T cells were plated in 96-well plates at a density of
2104 cells/well. Twenty-four hours later, the cells were trans-
fected with the NF-kB-luciferase and thymidine kinase promoter-
driven Renilla luciferase (TK-Renilla) reporter plasmids, 50 ng of
MyD88, TRAF6, p65, TBK1 or TRAF2 expression plasmids, with or
without US3 plasmid and pcDNA3.1 empty vector to keep the
total plasmid amount constant. Transfected cells were incubated
for 24 h at 37 1C before being analyzed for luciferase activity. To
determine luciferase expression, cells were lysed in 100 ml of
reporter lysis buffer, and ﬁreﬂy luciferase activity was measured
using the dual-glo luciferase assay system (Promega). Results are
presented as fold induction of luciferase activity of transfected
samples relative to the empty vector transfected control sample,
after normalizing the ﬁreﬂy luciferase activity of each sample to
J. Sen et al. / Virology 439 (2013) 65–7372its Renilla luciferase activity. For the US3 dose-dependence
reporter assay, TLR2-expressing cells (H2.14.12 cells) were trans-
fected with NF-kB-luciferase and TK-Renilla plasmids, together
with increasing amounts of US3-plasmid and pcDNA3.1 empty
vector to keep the total plasmid amount constant. After 24 h,
transfected cells were treated with Zymosan, and at 6 h post
stimulation ﬁreﬂy and Renilla luciferase activities were measured
using the Promega dual-glo luciferase assay system.
To measure IL-6 or IL-8 production, H2.14.12 or RAW cells
were infected with virus diluted in DMEM containing 1% calf
serum (DMEV) at the indicated MOI for 1 h at 37 1C. The virus
inoculum was replaced with DMEV and incubated at 37 1C. Cell
supernatants were collected at the indicated time points, and IL-6
or IL-8 levels were measured by ELISA using the OptEIA human
IL-6 or IL-8 ELISA kit (BD Biosciences, San Diego, CA) according to
the manufacturer’s protocol.
Cell fractionation
Virus-infected cells were washed with ice-cold PBS and lysed
in low-salt sucrose buffer (10 mM HEPES pH 7.9, 50 mM NaCl,
0.5 M sucrose, 0.1 mM EDTA, 0.5% Triton X-100 supplemented
with protease inhibitor cocktail) on ice for 10 min. Lysates were
clariﬁed by centrifugation at 1500 rpm at 4 1C for 5 min, and the
supernatant was saved as the cytoplasmic extract. Pellets were
washed once with low-salt buffer without sucrose, and the pellet
was further extracted with high-salt buffer (10 mM HEPES pH 7.9,
500 mM NaCl, 0.1 mM EDTA, 0.1% NP-40 supplemented with
protease inhibitor cocktail) to obtain nuclear extracts. Protein
levels in the cytoplasmic and nuclear fractions were determined
using the Bradford method of protein quantitation (Bio-Rad
Bradford reagent), and equivalent amounts of total protein in
lysate samples were resolved by SDS-PAGE and analyzed by
Western blotting to detect cytoplasmic and nuclear proteins.
Transfection and Immunoprecipitation
HEK293 T cells plated in 10 cm dishes were transfected with
the indicated plasmids using the calcium phosphate precipitation
method. At 24 h post transfection, cells were washed with ice–
cold PBS and harvested in RIPA buffer containing 1% NP-40, 0.5%
sodium deoxycholate, protease inhibitors and 20 mM iodoacetate.
For detecting endogenous TRAF6, H2.14.12 cells were infected in
10 cm culture plates, and cells were lysed in RIPA buffer as
described above. Aliquots of lysate containing equal amounts of
total protein were incubated with anti-TRAF6 antibody, immu-
noprecipitated with Protein-A-agarose beads and washed in RIPA
buffer. Bound proteins were eluted with Laemmli sample buffer,
resolved by SDS-PAGE, and transferred onto PVDF membrane.
Western blot analysis and antibodies used
PVDF membranes were blocked in 5% milk/TBST solution and
probed with anti-TRAF6, anti-Ubiquitin, anti-IkBa (Santa Cruz
Biotech), anti-p65 (Abcam), anti-HA (Clonetech), anti-V5 (Invitro-
gen) or anti-FLAG (SIGMA) antibodies. Secondary antibodies used
were HRP-conjugated anti-mouse and anti-rabbit antibodies from
Bio-Rad Laboratories. Blots were developed using enhanced
chemiluminescence (ECL) Western blotting reagents (Pierce).
RNA extraction and real-time PCR
RNA was isolated from RAW264.7 cells using the Qiagen
RNeasy Kit as per the manufacturer’s protocol. After quantiﬁca-
tion by spectrophotometry, equal amounts of RNA were subjected
to DNAse treatment (Ambion), reverse-transcribed using the highcapacity cDNA reverse transcription kit (Applied Biosystems), and
then quantiﬁed by real-time PCR using Sybr Green and the
following primers: mIL-6-F (50’-GAGGATACCACTCCCAACAGACC-
30), mIL-6-R (50-AAGTGCATCGGTGGTCATACA-30) (Koga et al.,
2008), mCCL2-F (50-TGACCCGTAAATCGTAAGC-30), mCCL2-R
(50-CGAGTCACACTAGTTCACTG-30) (Keepers et al., 2007). The
abundance of mRNA was normalized to that of GAPDH mRNA
and fold increase in RNA levels in infected cells compared to that
in mock infected samples was calculated using the DDCt method
(Livak and Schmittgen, 2001).Acknowledgments
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